Carbapenem resistance expressed by Gram-negative bacilli isolated from a cohort of Libyan patients

Simple item page
dc.contributor.authorShallouf, Mohamed
dc.contributor.authorAbrantes, Pedro Miguel dos Santos
dc.contributor.authorAfrica, Charlene W.J.
dc.date.accessioned2017-01-12T07:09:13Z
dc.date.available2017-01-12T07:09:13Z
dc.date.issued2016
dc.description.abstractBackground and objectives: Carbapenem-resistant Enterobacteriaceae (CRE) and other Gram-negative bacteria are among the most common pathogens responsible for both community and hospital acquired infection. The global spread of cephalosporinases in Enterobacteriaceae has led to the increased use of carbapenems resulting in the emergence and rapid spread of CRE. This has become an alarming public health concern, yet the condition in Libya remains unclear. The aim of this study was to obtain a better understanding of CRE strains prevalent in Libyan patients by investigating their phenotypic characteristics and antibiograms. Methods: Gram-negative bacterial species were collected from Misrata Central Hospital, Misrata Cancer Centre and Privet Pathology Laboratories. Clinical samples and swabs were obtained from hospitalised and non-hospitalised patients and from mechanical ventilation and suction machines. Patients who had received antibiotic therapy for at least three days prior to the study were excluded. The identification and characterization of the isolated species were achieved using the growth characteristics on MacConkey and blood agar, spot tests and API 20E or API 20NE biochemical testing systems. Screening for carbapenem resistance was performed using the disk diffusion method with carbapenem 10 μg and cephalosporin 30 μg disks and minimum inhibitory concentrations (MIC) determined using the Sensititre Gram-negative Xtra plate format (GNX2F). All strains demonstrating resistance or reduced susceptibility to one of the four carbapenems were subjected to carbapenememase activity detection using the RAPIDEC CARBA NP test, Modified Hodge test and carbapenem inactivation methods. Results: A total of one hundred and forty isolates representing fourteen bacterial species were isolated from 140 non-duplicated specimens. Clinical specimens included urine samples (96/140, 68.57%), sputum (15/140, 10.71%), surgical wound swabs (18/140, 12.85%), foot swabs from diabetes mellitus (DM) patients (6/140, 4.29%), ear swabs (3/140, 2.14%) and wound swabs (2/140, 1.43%). Thirty-four (24.29%) isolates demonstrated resistance to at least one of the four carbapenems with Klebsiella pneumoniae representing 73.53% (25 isolates) of all carbapenem resistant species, followed by 8.82% for Pseudomonas aeruginosa (3 isolates), 5.88% for both Proteus mirabilis (2 isolates) and Escherichia coli (2 isolates) and 2.94% for both Citrobacter koseri (1 isolate) and Rahnella aquatilis (1 isolate). The other isolates were either susceptible or cephalosporinase producers. Conclusion: This study has revealed the high rate of carbapenem resistance amongst Libyan patients and emphasizes the crucial need for accurate screening, identification and susceptibility testing to prevent further spread of nosocomial and community acquired resistance. This may be achieved through the establishment of antibiotic stewardship programmes along with firm infection control practices.en_US
dc.description.accreditationWeb of Science
dc.description.sponsorshipNational Research Foundation of South Africa; Libyan Governmenten_US
dc.identifier.citationShallouf, M., Abrantes, P.D.M.S., Africa, C.W.J. (2016). Carbapenem resistance expressed by Gram-negative bacilli isolated from a cohort of Libyan patients. Antimicrob Resist Infect Control 2016, 6(Suppl 1):A10en_US
dc.identifier.issn2047-2994
dc.identifier.otherDOI: 10.1186/s13756-016-0153-0
dc.identifier.urihttp://hdl.handle.net/10566/2483
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.relation.ispartofseries6th Infection Control Africa Network Congress Abstracts;A10
dc.rightsCopyright the Authors, who have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central license agreement.
dc.subjectDrug resistanceen_US
dc.subjectBacteriologyen_US
dc.titleCarbapenem resistance expressed by Gram-negative bacilli isolated from a cohort of Libyan patientsen_US
dc.typePresentationen_US

Files

Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
Mohamed.pdf
Size:
119.51 KB
Format:
Adobe Portable Document Format
Description:
Published abstract on Antimicrob Resist Infect Control Journal
Download
Thumbnail Image
Name:
ICAN 2016 Carbapenem resistance poster.pdf
Size:
1.68 MB
Format:
Adobe Portable Document Format
Description:
Poster
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Conference Papers (Medical Bioscience)